Achievement of early deep remission predicts better long-term outcomes for adalimumab-treated patients with Crohn's disease: Data from EXTEND.

被引：0
|
作者：
Sandborn, W. [1 ]
Colombel, J.
Rutgeerts, P. [2 ]
Yang, M. [3 ]
Lomax, K. [3 ]
Pollack, P. [3 ]
Thakkar, R. [3 ]
Camez, A. [4 ]
Chen, N. [3 ]
Chao, J. [3 ]
Mulani, P. [3 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Abbott GmbH & Co KG, Ludwigshafen, Germany
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Achievement of Early Deep Remission Predicts Better Long-Term Outcomes for Adalimumab-Treated Patients with Crohn's Disease: Data from EXTEND
    Colombel, Jean-Frederic
    Rutgeerts, Paul
    Sandborn, William
    Yang, Mei
    Lomax, Kathleen
    Pollack, Paul
    Thakkar, Roopal
    Camez, Anne
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S434 - S435
  • [2] Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with Crohn's disease: Data from EXTEND.
    Sandborn, W.
    Colombel, J.
    Lomax, K.
    Pollack, P.
    Thakkar, R.
    Camez, A.
    Chen, N.
    Yang, M.
    Chao, J.
    Mulani, P.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S61 - S61
  • [3] ACHIEVEMENT OF EARLY DEEP REMISSION IS ASSOCIATED WITH LOWER RATES OF WEEKLY DOSING FOR ADALIMUMAB-TREATED PATIENTS WITH CROHN'S DISEASE: DATA FROM EXTEND
    Sandborn, W. J.
    Colombel, J. F.
    Lomax, K. G.
    Pollack, P. F.
    Thakkar, R.
    Camez, A.
    Chen, N.
    Yang, M.
    Chao, J.
    Mulani, P. M.
    GUT, 2011, 60
  • [4] Achievement of Early Deep Remission Is Associated with Lower Rates of Weekly Dosing for Adalimumab-Treated Patients with Crohn's Disease: Data from EXTEND
    Sandborn, William
    Colombel, Jean-Frederic
    Lomax, Kathleen
    Pollack, Paul
    Thakkar, Roopal
    Camez, Anne
    Chen, Naijun
    Yang, Mei
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S442 - S443
  • [5] Economic Impact of Deep Remission in Adalimumab-Treated Patients With Crohn's Disease: Results From Extend
    Sandborn, William J.
    Colombel, Jean-Frederic
    Louis, Edouard
    Panaccione, Remo
    Yang, Mei
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2011, 140 (05) : S205 - S205
  • [6] Early Mucosal Healing Status Predicts Long-Term Clinical Benefits for Adalimumab-Treated Patients With Moderate to Severe Crohn's Disease
    Rutgeerts, Paul J.
    Reinisch, Walter
    Thakkar, Roopal
    Wu, Eric Q.
    Kaltenboeck, Anna
    Yang, Mei
    Mulani, Parvez
    Chao, Jingdong
    GASTROENTEROLOGY, 2010, 138 (05) : S85 - S85
  • [7] Early remission status predicts long-term outcomes in patients with Crohn's disease treated with certolizumab pegol
    Melmed, Gil Y.
    McGovern, Dermot
    Schreiber, Stefan
    Kosutic, Gordana
    Spearman, Marshall
    Coarse, Jason
    Sandborn, William J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) : 1937 - 1941
  • [8] Long-term deep remission after adalimumab discontinuation in Crohn's disease patients
    Melotti, L.
    Rizzello, F.
    Calabrese, C.
    Dussias, N.
    Gionchetti, P.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S423 - S423
  • [9] Crohn's Disease Mucosal Healing in Adalimumab-Treated Patients is Affected by Disease Duration: Results From Extend
    Sandborn, William J.
    Panaccione, Remo
    Thakkar, Roopal
    Lomax, Kathleen G.
    Chen, Naijun
    Chao, Jingdong
    Mulani, Parvez
    Yang, Mei
    GASTROENTEROLOGY, 2010, 138 (05) : S164 - S164
  • [10] Prediction of Long-Term Clinical Remission for Adalimumab-Treated Patients With Crohn's Disease by Identification of Appropriate Dichotomizing Points for SES-CD
    Reinisch, Walter
    Rutgeerts, Paul J.
    Panaccione, Remo
    D'Haens, Geert R.
    Thakkar, Roopal
    Yu, Andrew P.
    Li, Zhiyi
    Camez, Anne A.
    Pollack, Paul F.
    Yang, Mei
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2010, 138 (05) : S8 - S8
12345